Items where Author is "Mafi, A."

(2025) Circular RNAs and doxorubicin resistance in cancer: molecular mechanisms and potential treatment targets. Gene. p. 16. ISSN 0378-1119

(2025) Crosstalk between noncoding RNAs and autophagy in renal cell carcinoma: Deciphering molecular pathways and therapeutic prospects. Cancer Cell International. p. 33.

(2025) Effect of Saffron (Crocus sativus) Supplementation on Oxidative Stress, Inflammatory Indices, and Renal and Liver Function Parameters in Patients With Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Clinical Trials. Nutrition reviews. pp. 971-987. ISSN 1753-4887 (Electronic) 0029-6643 (Linking)

(2025) Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Current gene therapy. pp. 72-88. ISSN 1875-5631 (Electronic) 1566-5232 (Linking)

(2025) Insight into the cardioprotective effects of melatonin: shining a spotlight on intercellular Sirt signaling communication. Molecular and Cellular Biochemistry. pp. 799-823. ISSN 1573-4919 (Electronic) 0300-8177 (Linking)

(2025) Interplay between LncRNAs and autophagy-related pathways in leukemia: mechanisms and clinical implications. Medical Oncology. p. 21. ISSN 1357-0560

(2025) Long noncoding RNAs and HPV-related cervical cancer: Uncovering molecular mechanisms and clinical applications. Translational Oncology. p. 18. ISSN 1936-5233

(2025) Modulation of Long Non-coding RNAs and MicroRNAs by Quercetin as a Potential Therapeutical Approach in Cancer: A Comprehensive Review. Current medicinal chemistry. pp. 1264-1275. ISSN 1875-533X (Electronic) 0929-8673 (Linking)

(2025) Recent Insights into the Angioregulatory Role of Long Non-coding RNAs and Circular RNAs in Gliomas: From Signaling Pathways to Clinical Aspects. Current Medicinal Chemistry. pp. 3169-3192. ISSN 1875-533X (Electronic) 0929-8673 (Linking)

(2025) The role of curcumin in modulating circular RNAs and long non-coding RNAs in cancer. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. pp. 2416-2436. ISSN 1699-3055 (Electronic) 1699-048X (Linking)

(2024) Circular RNAs and cervical cancer: friends or foes? A landscape on circRNA-mediated regulation of key signaling pathways involved in the onset and progression of HPV-related cervical neoplasms. Cell Communication and Signaling. p. 21.

(2024) Circular RNAs: Emerging Modulators in the Pathophysiology of Polycystic Ovary Syndrome and their Clinical Implications. Current Molecular Medicine. pp. 153-166. ISSN 1566-5240

(2024) Effect of Saffron (Crocus sativus) Supplementation on Oxidative Stress, Inflammatory Indices, and Renal and Liver Function Parameters in Patients With Type 2 Diabetes Mellitus: A GRADE-Assessed Systematic Review and Meta-analysis of Randomized Clinical Trials. Nutrition Reviews. p. 17. ISSN 0029-6643

(2024) Efficacy and Safety of Pembrolizumab Monotherapy or Combined Therapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Current Gene Therapy. pp. 72-88. ISSN 1566-5232

(2024) Liver Disorders Caused by Inborn Errors of Metabolism. Endocrine Metabolic & Immune Disorders-Drug Targets. pp. 194-207. ISSN 1871-5303

(2024) Mechanistic insights into circRNA-mediated regulation of PI3K signaling pathway in glioma progression. Pathology Research and Practice. p. 11. ISSN 0344-0338

(2024) MicroRNA dysregulation and its impact on apoptosis-related signaling pathways in myelodysplastic syndrome. Pathology Research and Practice. p. 10. ISSN 0344-0338

(2024) New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment. Current Medicinal Chemistry. pp. 1404-1426. ISSN 0929-8673

(2024) Non-coding RNAs in leukemia drug resistance: new perspectives on molecular mechanisms and signaling pathways. Annals of hematology. pp. 1455-1482. ISSN 1432-0584 (Electronic) 0939-5555 (Linking)

(2024) Recent Insights into the Angioregulatory Role of Long Non-coding RNAs and Circular RNAs in Gliomas: From Signaling Pathways to Clinical Aspects. Current Medicinal Chemistry. p. 24. ISSN 0929-8673

(2024) Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy. Current Molecular Pharmacology. p. 21. ISSN 1874-4672

(2024) Resveratrol-loaded nanocarriers: Characteristics, sources, health effects, recent delivery systems, and their food and biomedical applications. Food Bioscience. p. 20. ISSN 2212-4292

(2024) Role of long noncoding RNAs in pathological cardiac remodeling after myocardial infarction: An emerging insight into molecular mechanisms and therapeutic potential. Biomedicine & Pharmacotherapy. p. 15. ISSN 0753-3322

(2024) Unfolded Protein Response Signaling in Hepatic Stem Cell Activation in Liver Fibrosis. Current Protein & Peptide Science. pp. 59-70. ISSN 1389-2037

(2024) The beneficial effects of crocin supplementation on metabolic and genetic parameters in type 2 diabetic patients under metformin treatment: A randomized double-blind controlled clinical trial. Journal of Functional Foods. p. 11. ISSN 1756-4646

(2024) The emerging role of circular RNAs in cisplatin resistance in ovarian cancer: From molecular mechanism to future potential. Non-Coding Rna Research. pp. 1280-1291. ISSN 2468-2160

(2024) The function and mechanism of circRNAs in 5-fluorouracil resistance in tumors: Biological mechanisms and future potential. Pathology Research and Practice. p. 12. ISSN 0344-0338

(2024) The importance of the circRNA/Wnt axis in gliomas: Biological functions and clinical opportunities. Pathology Research and Practice. p. 13. ISSN 0344-0338

(2024) The landscape of circRNAs in gliomas temozolomide resistance: Insights into molecular pathways. Non-Coding Rna Research. pp. 1178-1189. ISSN 2468-2160

(2024) The potential role of circular RNAs -regulated PI3K signaling in non-small cell lung cancer: Molecular insights and clinical perspective. Pathology Research and Practice. p. 10. ISSN 0344-0338

(2024) The role of curcumin in modulating circular RNAs and long non-coding RNAs in cancer. Clinical & Translational Oncology. p. 21. ISSN 1699-048X

(2023) CIRCULAR RNAS: NOVEL ACTORS OF WNT SIGNALING PATHWAY IN LUNG CANCER PROGRESSION. Excli Journal. pp. 645-669. ISSN 1611-2156

(2023) Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets. Cns & Neurological Disorders-Drug Targets. pp. 1335-1354. ISSN 1871-5273

(2023) Circular RNAs: pivotal role in the leukemogenesis and novel indicators for the diagnosis and prognosis of acute myeloid leukemia. Frontiers in Oncology. p. 25. ISSN 2234-943X

(2023) Correlation of Expression of MMP-2, ACE2, and TMPRSS2 Genes with Lymphopenia for Mild and Severity of COVID-19. Iranian Journal of Allergy Asthma and Immunology. pp. 91-98. ISSN 1735-1502

(2023) Efficacy and Safety of Atezolizumab Monotherapy or Combined Therapy with Chemotherapy in Patients with Metastatic Triple-negative Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Current Pharmaceutical Design. pp. 2461-2476. ISSN 1381-6128

(2023) Impact of polyphenols on heart failure and cardiac hypertrophy: clinical effects and molecular mechanisms. Frontiers in Cardiovascular Medicine. p. 23. ISSN 2297-055X

(2023) Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy. Cell Communication and Signaling. p. 17.

(2023) Melatonin as a regulator of apoptosis in leukaemia: molecular mechanism and therapeutic perspectives. Frontiers in Pharmacology. p. 11.

(2023) Melatonin targeting non-coding RNAs in cancer: Focus on mechanisms and potential therapeutic targets. European Journal of Pharmacology. p. 10. ISSN 0014-2999

(2023) Possible Mechanisms and Molecular Signaling of Incretins against the Development of Type 2 Diabetes Mellitus. Current Molecular Pharmacology. pp. 448-464. ISSN 1874-4672

(2023) Regulating miRNAs Expression by Resveratrol: Novel Insights based on Molecular Mechanism and Strategies for Cancer Therapy. Current Molecular Pharmacology. ISSN 1874-4702 (Electronic) 1874-4672 (Linking)

(2023) The Significant Role of microRNAs in Gliomas Angiogenesis: A Particular Focus on Molecular Mechanisms and Opportunities for Clinical Application. Cellular and Molecular Neurobiology. pp. 3277-3299. ISSN 0272-4340

(2023) Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence and Perspectives. Mini-Reviews in Medicinal Chemistry. pp. 1167-1192. ISSN 1389-5575

(2023) The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms. Frontiers in Pharmacology. p. 19.

(2023) A spotlight on the interplay between Wnt/β-catenin signaling and circular RNAs in hepatocellular carcinoma progression. Frontiers in Oncology. p. 11. ISSN 2234-943X

(2022) Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms. CELL COMMUNICATION AND SIGNALING. ISSN 1478-811X J9 - CELL COMMUN SIGNAL

(2022) Circular RNAs in Alzheimer's Disease: A New Perspective of Diagnostic and Therapeutic Targets. CNS Neurol Disord Drug Targets. ISSN 1871-5273

(2022) Possible mechanisms and molecular signaling of incretins against the development of type 2 diabetes mellitus. Curr Mol Pharmacol. ISSN 1874-4672

(2022) Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment. Cellular & molecular biology letters. p. 65. ISSN 1689-1392 (Electronic) 1425-8153 (Print) 1425-8153 (Linking)

(2022) Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment. CELLULAR & MOLECULAR BIOLOGY LETTERS. ISSN 1425-8153 1689-1392 J9 - CELL MOL BIOL LETT

(2022) Targeting Glioma Cells with Nutraceuticals: Therapeutic Effects Based on Molecular Mechanisms, New Evidence, and Perspectives. Mini Rev Med Chem. ISSN 1389-5575

(2022) Therapeutic Potential of Resveratrol in Diabetic Nephropathy According to Molecular Signaling. CURRENT MOLECULAR PHARMACOLOGY. pp. 716-735. ISSN 1874-4672 1874-4702 J9 - CURR MOL PHARMACOL

(2021) Circular RNAs; powerful microRNA sponges to overcome diabetic nephropathy. PATHOLOGY RESEARCH AND PRACTICE. ISSN 0344-0338 1618-0631 J9 - PATHOL RES PRACT